Jasper Ridge Partners »

Cytokinetics shares owned by Jasper Ridge Partners

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Jasper Ridge Partners from 13F filings

Historical chart of Jasper Ridge Partners investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Jasper Ridge Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Jasper Ridge Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $350k 5.5k 63.54

More positions owned by Jasper Ridge Partners

Vanguard Tax-managed Intl Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Val Etf (IWD)
Nike CL B (NKE)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 2000 Val Etf (IWN)
Roblox Corp Cl A (RBLX)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Unity Software (U)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)

View all positions for Jasper Ridge Partners

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics